79 related articles for article (PubMed ID: 12705885)
21. Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1.
Feng YH; Sun Y; Douglas JG
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12049-54. PubMed ID: 12221292
[TBL] [Abstract][Full Text] [Related]
22. Src homology region 2 domain-containing phosphatase 1 positively regulates B cell receptor-induced apoptosis by modulating association of B cell linker protein with Nck and activation of c-Jun NH2-terminal kinase.
Mizuno K; Tagawa Y; Mitomo K; Watanabe N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2002 Jul; 169(2):778-86. PubMed ID: 12097380
[TBL] [Abstract][Full Text] [Related]
23. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
[TBL] [Abstract][Full Text] [Related]
24. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
Yusa S; Catina TL; Campbell KS
J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
[TBL] [Abstract][Full Text] [Related]
25. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.
Gavrieli M; Watanabe N; Loftin SK; Murphy TL; Murphy KM
Biochem Biophys Res Commun; 2003 Dec; 312(4):1236-43. PubMed ID: 14652006
[TBL] [Abstract][Full Text] [Related]
26. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.
Dustin LB; Plas DR; Wong J; Hu YT; Soto C; Chan AC; Thomas ML
J Immunol; 1999 Mar; 162(5):2717-24. PubMed ID: 10072516
[TBL] [Abstract][Full Text] [Related]
27. Dual regulation of BCR-mediated growth inhibition signaling by CD72.
Baba T; Fusaki N; Aoyama A; Li DH; Okamura RM; Parnes JR; Hozumi N
Eur J Immunol; 2005 May; 35(5):1634-42. PubMed ID: 15816000
[TBL] [Abstract][Full Text] [Related]
28. SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line.
Motoda K; Takata M; Kiura K; Nakamura I; Harada M
Immunology; 2000 Jul; 100(3):370-7. PubMed ID: 10929060
[TBL] [Abstract][Full Text] [Related]
29. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1.
Greer SF; Justement LB
J Immunol; 1999 May; 162(9):5278-86. PubMed ID: 10228003
[TBL] [Abstract][Full Text] [Related]
30. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
31. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
Paling NR; Welham MJ
Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells.
Mizuno K; Katagiri T; Hasegawa K; Ogimoto M; Yakura H
J Exp Med; 1996 Aug; 184(2):457-63. PubMed ID: 8760799
[TBL] [Abstract][Full Text] [Related]
33. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
Wheadon H; Edmead C; Welham MJ
Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
[TBL] [Abstract][Full Text] [Related]
34. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
[TBL] [Abstract][Full Text] [Related]
35. Positive regulation of c-Jun N-terminal kinase and TNF-alpha production but not histamine release by SHP-1 in RBL-2H3 mast cells.
Xie ZH; Zhang J; Siraganian RP
J Immunol; 2000 Feb; 164(3):1521-8. PubMed ID: 10640770
[TBL] [Abstract][Full Text] [Related]
36. The motheaten mutation rescues B cell signaling and development in CD45-deficient mice.
Pani G; Siminovitch KA; Paige CJ
J Exp Med; 1997 Aug; 186(4):581-8. PubMed ID: 9254656
[TBL] [Abstract][Full Text] [Related]
37. Localization of Src homology 2 domain-containing phosphatase 1 (SHP-1) to lipid rafts in T lymphocytes: functional implications and a role for the SHP-1 carboxyl terminus.
Fawcett VC; Lorenz U
J Immunol; 2005 Mar; 174(5):2849-59. PubMed ID: 15728495
[TBL] [Abstract][Full Text] [Related]
38. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
Yusa S; Campbell KS
J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
[TBL] [Abstract][Full Text] [Related]
39. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal.
Maeda A; Kurosaki M; Ono M; Takai T; Kurosaki T
J Exp Med; 1998 Apr; 187(8):1355-60. PubMed ID: 9547347
[TBL] [Abstract][Full Text] [Related]
40. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
